Literature DB >> 35232858

Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India.

Mainak Banerjee1, Rimesh Pal2, Sanjay K Bhadada3.   

Abstract

Entities:  

Keywords:  COVID-19; infectious diseases

Mesh：

Year:  2022        PMID： 35232858     DOI： 10.1136/postgradmedj-2021-140537

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  4 in total

1.  Sensitivity of liquid-based cytology in the diagnosis of mucormycosis in COVID-19 treated patients.

Authors:  Rabish Kumar; Meeta Singh; Tanu Sagar; M Bharanidharan; Nita Khurana; Vikas Kumar; Ravi Meher; Vikas Malhotra; Ruchi Goel; Sonal Saxena; Jyoti Kumar
Journal:  Cytopathology       Date:  2022-04-18       Impact factor: 1.286

2.  Epidemiology of Mucormycosis Cases During the Second Wave of COVID-19 in a Tertiary Care Institute in Western Rajasthan, India.

Authors:  Arun Kumar; Manoj Verma; Afzal Hakim; Savitri Sharma; Rita Meena; Suman Bhansali
Journal:  Cureus       Date:  2022-03-08

3.  Alternate Special Stains for the Detection of Mycotic Organisms in Oral Cyto-Smears-A Histomorphometric Study.

Authors:  S V Sowmya; Dominic Augustine; Beena Hemanth; Arcot Gopal Prathab; Ahmed Alamoudi; Hammam Ahmed Bahammam; Sarah Ahmed Bahammam; Maha A Bahammam; Vanishri C Haragannavar; Sonia Prabhu; Shankargouda Patil
Journal:  Microorganisms       Date:  2022-06-15

4.  Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.

Authors:  Ali Sharifi; Zahra Akbari; Mohammad Shafie'ei; Naser Nasiri; Meraj Sharifi; Mohadeseh Shafiei; Amin Zand
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2022-08-08       Impact factor: 2.011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.